LIVN
LivaNova PLC Ordinary Shares
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$46.630
Максимум
$46.630
Минимум
$46.630
Объем
0.67M
Фундаментальные показатели компании
Статистические данные торговли
Связанные новости
CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
Final critical papers on RECOVER clinical study data accepted, supporting the Company's submission for coverage reconsideration Strong 24-month top-line data for RECOVER clinical study demonstrates durability of VNS
Wolfe Research Upgrades LivaNova to Outperform, Announces $60 Price Target
Wolfe Research analyst Mike Polark upgrades LivaNova from Peer Perform to Outperform and announces $60 price target.
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.